Sunflower Pharmaceutical Group Co.,Ltd

SZSE:002737 Stock Report

Market Cap: CN¥12.0b

Sunflower Pharmaceutical GroupLtd Balance Sheet Health

Financial Health criteria checks 6/6

Sunflower Pharmaceutical GroupLtd has a total shareholder equity of CN¥4.7B and total debt of CN¥609.7K, which brings its debt-to-equity ratio to 0.01%. Its total assets and total liabilities are CN¥5.9B and CN¥1.2B respectively. Sunflower Pharmaceutical GroupLtd's EBIT is CN¥891.3M making its interest coverage ratio -13.8. It has cash and short-term investments of CN¥2.2B.

Key information

0.01%

Debt to equity ratio

CN¥609.65k

Debt

Interest coverage ratio-13.8x
CashCN¥2.20b
EquityCN¥4.70b
Total liabilitiesCN¥1.23b
Total assetsCN¥5.93b

Recent financial health updates

No updates

Recent updates

We Believe That Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Weak Earnings Are A Good Indicator Of Underlying Profitability

Nov 04
We Believe That Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Weak Earnings Are A Good Indicator Of Underlying Profitability

A Look At The Intrinsic Value Of Sunflower Pharmaceutical Group Co.,Ltd (SZSE:002737)

Aug 26
A Look At The Intrinsic Value Of Sunflower Pharmaceutical Group Co.,Ltd (SZSE:002737)

Lacklustre Performance Is Driving Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Low P/E

Jul 19
Lacklustre Performance Is Driving Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Low P/E

Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Shareholders Will Receive A Bigger Dividend Than Last Year

Jun 07
Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Shareholders Will Receive A Bigger Dividend Than Last Year

Earnings Troubles May Signal Larger Issues for Sunflower Pharmaceutical GroupLtd (SZSE:002737) Shareholders

May 06
Earnings Troubles May Signal Larger Issues for Sunflower Pharmaceutical GroupLtd (SZSE:002737) Shareholders

Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Subdued P/E Might Signal An Opportunity

Apr 16
Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Subdued P/E Might Signal An Opportunity

We Ran A Stock Scan For Earnings Growth And Sunflower Pharmaceutical GroupLtd (SZSE:002737) Passed With Ease

Mar 04
We Ran A Stock Scan For Earnings Growth And Sunflower Pharmaceutical GroupLtd (SZSE:002737) Passed With Ease

Financial Position Analysis

Short Term Liabilities: 002737's short term assets (CN¥3.9B) exceed its short term liabilities (CN¥980.7M).

Long Term Liabilities: 002737's short term assets (CN¥3.9B) exceed its long term liabilities (CN¥252.7M).


Debt to Equity History and Analysis

Debt Level: 002737 has more cash than its total debt.

Reducing Debt: 002737's debt to equity ratio has reduced from 13.4% to 0.01% over the past 5 years.

Debt Coverage: 002737's debt is well covered by operating cash flow (16894%).

Interest Coverage: 002737 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies